Teva Pharmaceuticals "pivot to growth" strategy under CEO Richard Francis aims to use a combination of biosimilars, generics, ...

Intech Investment Management LLC purchased a new stake in Teva Pharmaceutical Industries Limited (NYSE:TEVA – Free Report) in ...

Teva's reasonable valuation, an improving pipeline, and sales and profit growth potential are good enough reasons for those ...

Swiss drugmaker Novartis will pay up to $2.9 billion for PTC Therapeutics' promising experimental drug for a neurological ...

Teva Pharmaceutical Industries Limited (NYSE:TEVA – Get Free Report) has received a consensus recommendation of “Moderate Buy ...

In terms of liquidity and interest, the mean open interest for Teva Pharmaceutical Indus options trades today is 8263.67 with ...

Exactly how Baltimore will spend $669 million from opioid lawsuits and settlements is starting to come into focus.

Last year, we took bold steps to ensure our sites were addressing antimicrobial resistance (AMR) throughout the entire ...

Today, Benzinga's options scanner spotted 25 options trades for Teva Pharmaceutical Indus. This is not a typical pattern. The sentiment among these major traders is split, with 24% bullish and 60% ...

We recently published a list of 12 Best Stocks Under $25 To Invest In Right Now. In this article, we are going to take a look ...